ArticleFrontiers in public health2022

Cost-effectiveness analysis of capecitabine maintenance therapy plus best supportive care vs. best supportive care alone as first-line treatment of newly diagnosed metastatic nasopharyngeal carcinoma.

Jiaqi Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.